Patient Experiences of Digital Technology Use in Interstitial Lung Disease (PRODIGY-ILD Study): Qualitative Study Using Reflexive Thematic Analysis
Gunne et al.
The finding, in our words
In a qualitative study of fifteen people with interstitial lung disease, sustained engagement with wearable devices and remote monitoring over three years was driven by trust in researchers and altruism, while limited by digital literacy barriers and symptom burden. The findings underscore that decentralised diagnostics require patient-centric design, flexible procedures and tailored support to maintain adherence in chronic disease populations.
A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.
A hybrid decentralised clinical trial using wearable dosing-monitoring and remote adverse-event reporting in healthy adults achieved 100% adherence with only 2% missing data, maintained adverse-event detection sensitivity, and was rated less burdensome than conventional on-site visits. These findings support the feasibility and reliability of participant-centric remote monitoring in early-phase pharmacokinetic studies.
Kim et al., Clinical and translational science · source ↗
Older adults with and without cognitive impairment were motivated to participate in longitudinal remote sleep research, finding it acceptable when device burden was low, usability high, and adequate support enabled routine integration. Varying cognitive task content and allowing timing flexibility reduced fatigue, while diverse recruitment remains needed for equitable representation in decentralised dementia trials.
Biswas et al., Journal of medical Internet research · source ↗
The study observed favourable trends in the accrual of participants residing far from the site and those from underrepresented groups following the implementation of a decentralised clinical trial program.
A fully remote decentralised clinical trial in Danish adults with type 2 diabetes demonstrated operational feasibility with rapid recruitment, high retention (87 percent), and excellent adherence to continuous glucose monitoring (95 percent achieving ≥70 percent data coverage) and telemedicine visits (97 percent). Activity tracker adherence was poor (12 percent) due to technical issues, but remote safety monitoring was effective with no unexpected adverse events, supporting the viability of remote diabetes management.
A proof-of-concept decentralised trial generated 169 support tickets over 17 months from 90% of sites, with device-related problems accounting for 46% of requests. Most issues were resolved within three days and required two to six exchanges, demonstrating that robust technical support infrastructure is essential for successful remote monitoring and wearable-based trial conduct.
Weitlaner et al., Journal of medical systems · source ↗